Advanced Melanoma Market Size In 2026: Growth Outlook And Forecast Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Advanced Melanoma Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The market for advanced melanoma has seen substantial growth over recent years. It is projected to expand from $4.12 billion in 2025 to $4.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. The historical expansion can be linked to several contributing factors, including restricted treatment choices for advanced stages, an escalation in melanoma incidence rates, the growing infrastructure of hospitals and oncology centers, increased awareness regarding skin cancer, and the uptake of conventional chemotherapy and biological therapies.
The advanced melanoma market size is projected to experience robust growth in the coming years. It is anticipated to expand to $6.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period can be attributed to several factors, including advancements in immune checkpoint inhibitors, the increasing application of targeted therapies such as BRAF and MEK inhibitors, the broader adoption of personalized medicine approaches, growing investment in melanoma research, and the integration of digital health and patient monitoring solutions. Significant trends for the forecast period encompass a rising embrace of immunotherapy and targeted therapies, an increased utilization of biomarker-based treatment selection, an expansion in the capabilities of hospitals and oncology centers, a heightened focus on tools for early detection and diagnosis, and an increase in clinical trials and research dedicated to advanced melanoma.
Get A Free Sample Report With In-Depth Market Insights:
Advanced Melanoma Market Growth Factors: What’s Supporting Expansion?
The rising incidence of severe sunburns is anticipated to fuel the expansion of the advanced melanoma market. Severe sunburns are intense skin burns resulting from excessive ultraviolet (UV) radiation exposure, characterized by redness, discomfort, swelling, and sometimes blistering. The heightened occurrence of severe sunburn cases stems from prolonged UV radiation exposure, insufficient sun protection measures, increased outdoor activities during peak UV hours, and temperature increases attributed to climate change. Such sunburns, particularly recurrent ones or those sustained early in life, inflict DNA damage on skin cells, potentially leading to genetic mutations that initiate melanoma. For example, as reported in May 2024 by Melanoma Focus, a UK-based charity supporting the melanoma community, the period of 2022-23 saw 201 hospital admissions for sunburn, comprising 89 children and 25 infants under one year old. Additionally, 66% of UK adults aged 16-65 recalled experiencing sunburn as children, with 65% having suffered severe sunburns accompanied by blisters at least once. This percentage climbed to 77% for individuals with light, pale, or white skin. Consequently, the growing number of severe sunburn incidents is propelling the advanced melanoma market forward.
Advanced Melanoma Market Segmentation: How Does The Market Break Down By Category?
The advanced melanoma market covered in this report is segmented –
1) By Therapeutics: Chemotherapy, Biological Therapy, Targeted Therapy, Immune Therapy
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End-User: Hospitals, Cancer Research Centres, Academic Institutes, Diagnostic Centers, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors, Other Chemotherapy Drugs
2) By Biological Therapy: Monoclonal Antibodies, Interferons, Interleukins
3) By Targeted Therapy: BRAF Inhibitors, MEK Inhibitors, KIT Inhibitors, Other Targeted Therapies
4) By Immune Therapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Oncolytic Virus Therapy, Adoptive Cell Transfer
Advanced Melanoma Market Industry Trends: What’s Reshaping Demand?
Major companies in the advanced melanoma market are directing their efforts towards developing innovative products, like personalized vaccines, to boost treatment efficacy, overcome resistance mechanisms, and provide individualized treatment options, aiming for better patient outcomes and prolonged survival. A personalized vaccine for advanced melanoma is a form of cancer treatment specifically tailored for an individual patient, based on the unique genetic mutations present in their tumor. For instance, in April 2023, Merck & Co. Inc., a US-based pharmaceutical company, and Moderna Inc., a US-based biotechnology company, were granted Priority Medicines (PRIME) scheme designation by the European Medicines Agency (EMA) for their investigational personalized mRNA cancer vaccine, mRNA-4157/V940, when utilized in combination with Merck’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab) for the adjuvant treatment of patients with high-risk stage III/IV melanoma following complete resection. The personalized cancer vaccine mRNA-4157/V940 contains a single synthetic mRNA that codes for up to 34 neoantigens and is engineered and produced based on the unique mutational signature of the patient’s tumor.
Advanced Melanoma Market Competitive Overview And Top Companies
Major companies operating in the advanced melanoma market are Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co. Inc., Bristol-Myers Squibb, AstraZeneca AG, Novartis AG, Amgen Inc., BioNTech SE, Regeneron Pharmaceuticals, Genentech Inc., Exelixis Inc., Dynavax Technologies, Replimune Group, Immunocore Holdings plc, Xencor Inc., Agenus Inc., Nektar Therapeutics, Iovance Biotherapeutics, Adaptimmune Therapeutics, Immutep Ltd., Lytix Biopharma
View The Full Advanced Melanoma Market Report:
Advanced Melanoma Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the advanced melanoma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced melanoma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
